XOMA Royalty (XOMA) Total Non-Current Liabilities (2010 - 2026)

XOMA Royalty (XOMA) reported Total Non-Current Liabilities of $155.3 million for Q1 2026, up 24.39% on a YoY basis from $124.8 million in Q1 2025, and down 5.98% sequentially from $165.1 million in Q4 2025.

XOMA Royalty (XOMA) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 15 years of Total Non-Current Liabilities data on file, last reported at $155.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 24.39% year-over-year to $155.3 million; the trailing twelve-month figure through Mar 2026 stood at $155.3 million (up 24.39% YoY), and the FY2025 full-year result was $165.1 million, up 21.3% from the prior year.
  • Total Non-Current Liabilities fell to $155.3 million in Q1 2026, from $165.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $165.1 million in Q4 2025 to a low of $124.8 million in Q1 2025.
  • A 3-year average of $140.7 million and a median of $136.1 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities retreated 9.09% in 2025 and gained 24.39% in 2026, its largest moves.
  • Tracing XOMA's Total Non-Current Liabilities over 3 years: stood at $136.1 million in 2024, then advanced by 21.3% to $165.1 million in 2025, then dropped by 5.98% to $155.3 million in 2026.
  • Business Quant data shows XOMA's Total Non-Current Liabilities at $155.3 million in Q1 2026, $165.1 million in Q4 2025, and $127.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - 155.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 155.26 Mn
Dec 31, 2025 165.14 Mn
Jun 30, 2025 127.60 Mn
Mar 31, 2025 124.81 Mn
Dec 31, 2024 136.14 Mn
Sep 30, 2024 135.41 Mn
Jun 30, 2024 140.37 Mn
Sep 30, 2021 18.90 Mn
Jun 30, 2021 19.15 Mn
Mar 31, 2021 38.07 Mn
Dec 31, 2020 38.81 Mn
Sep 30, 2020 47.55 Mn
Jun 30, 2020 49.43 Mn
Mar 31, 2020 50.47 Mn
Dec 31, 2019 51.69 Mn
Sep 30, 2019 59.85 Mn
Jun 30, 2019 57.05 Mn
Mar 31, 2019 51.61 Mn
Dec 31, 2018 44.41 Mn
Sep 30, 2018 44.18 Mn